Clinical spectrum of the central nervous system tuberculosis in the National Center of Tuberculosis and Pulmonary Diseases in Tbilisi, and the difficulties of its diagnosis

Authors

  • Z. R. Avaliani National Center of Tuberculosis and Pulmonary Diseases, Tbilisi, Georgia
  • Sh. R. Sabanadze National Center of Tuberculosis and Pulmonary Diseases, Tbilisi, Georgia
  • T. D. Bakuradze National Center of Tuberculosis and Pulmonary Diseases, Tbilisi, Georgia
  • L.O Trapaidze National Center of Tuberculosis and Pulmonary Diseases, Tbilisi, Georgia
  • N. G Uznadze National Center of Tuberculosis and Pulmonary Diseases, Tbilisi, Georgia

DOI:

https://doi.org/10.61699/cjmps-v1-i2-3-p31-50

Keywords:

Tuberculous meningitis, tuberculosis, tuberculosis of the central nervous system, diagnosis, GeneXpert MTB / RIF, GeneXpert MTB / RIF ultra

Abstract

Against the background of the global HIV epidemic, tuberculosis meningitis remains the most severe and life-threatening form of tuberculosis. The purpose of the study: to prepare a retrospective analysis of the clinical features of tuberculosis of the central nervous system for 2015-2022 according to the data of the National Center of Tuberculosis and Pulmonary Diseases in Tbilisi. During the study period, tuberculosis of the central nervous system was detected in 414 patients. Of these, 248 patients were diagnosed with meningitis, 139 with meningoencephalitis, 6 with cerebral tuberculosis, 12 with myelitis, and 9 with polyradiculopathy. The diagnosis was carried out according to the WHO-recommended standardized laboratory methods, which formed the basis of the National Tuberculosis Control Program. The establishment of meningoencephalitis in 139 patients at the time of admission to the hospital indicates a late diagnosis. Treatment of patients with clinical suspicion of tuberculosis of the central nervous system should be carried out without waiting for laboratory confirmation of the diagnosis since the treatment of infection is most effective in the early stages of the disease. Timely diagnosis and the beginning of adequate treatment significantly reduce the incidence of complications of the disease and mortality.

References

Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis, second edition. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.

Global tuberculosis report 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(22)00359-7/fulltextGlobal tuberculosis report 2022. Geneva: World Health Organization; 2022. https://worldhealthorg.shinyapps.io/tb_profiles/?_inputs_&entity_type=%22country%22&lan=%22RU%22&iso2=%22GE%22

WHO announces updated definitions of extensively drug-resistant tuberculosis https://www.who.int/news/item/27-01-2021-who-announces-updated-definitions-of-extensively-drug-resistant-tuberculosis

Tuberculosis deaths and disease increase during the COVID-19 pandemic// https://www.who.int/news/item/27-10-2022-tuberculosis-deaths-and-disease-increase-during-the-covid-19-pandemic

WHO steps up the Director-General’s flagship initiative to combat tuberculosis https://www.who.int/news/item/23-03-2023-who-steps-up-the-director-general-s-flagship-initiative-to-combat-tuberculosis

Tsinzerling V.A., Chukhlovina M.L. Infectious lesion of nervous system: the questions of etiology, pathogenesis and diagnostics: manual for doctors. Saint-Petersburg: ELBI-SPb, 2011, 584 p. (in Russ.)

Leonard JM. Central Nervous System Tuberculosis. Microbiol Spectr. 2017;5(2):10.1128/microbiolspec.TNMI7-0044-2017.doi:10.1128/microbiolspec.TNMI7-0044-2017.

Schaller MA, Wicke F, Foerch C, Weidauer S. Central Nervous System Tuberculosis : Etiology, Clinical Manifestations and Neuroradiological Features. Clin Neuroradiol. 2019;29(1):3-18. doi:10.1007/s00062-018-0726-9

Sinitsyn M.V., Bogorodskaya E.M., Rodina O.V., Kubrakova E.P., Romanova E.Yu., Bugun A.V. The damage of the central nervous system in the patients with tuberculosis in modern epidemiological conditions. Infectious Diseases: News, Opinions, Training. 2018; 7 (1): 111–20.

Chugaev Yu.P., Skornyakov S.N., Kamaeva N.G., Grinberg L.B., Teryaeva M.V. et al. Tuberculosis of the meninges in children and adults/Methodological recommendations for detection, diagnosis and treatment, Part 2. Medical Alliance. – 2015. - No. 3. – pp. 24-31.

Rakisheva A.S., Arbuzova E.V. Tuberculous meningitis in modern conditions (literature review) // Bulletin of the Kazakh National Medical University. – 2020. - No. 4. – pp. 300-30512. Wang MS, Wang JL, Liu XJ, Zhang YA. The Sensitivity of Diagnostic Criteria of Marais S, et al. in Confirmed Childhood Tuberculous Meningitis. Front Pediatr. 2022;10:832694. Published 2022 Feb 16. doi:10.3389/fped.2022.832694

Dendane T, Madani N, Zekraoui A, et al. A simple diagnostic aid for tuberculous meningitis in adults in Morocco by use of clinical and laboratory features. Int J Infect Dis. 2013;17(6):e461-e465. doi:10.1016/j.ijid.2013.01.026

Luo M, Wang W, Zeng Q, Luo Y, Yang H, Yang X. Tuberculous meningitis diagnosis and treatment in adults: A series of 189 suspected cases. Exp Ther Med. 2018;16(3):2770-2776. doi:10.3892/etm.2018.6496

Verma R, Sarkar S, Garg RK, Malhotra HS, Sharma PK, Saxena S. Ophthalmological manifestation in patients of tuberculous meningitis. QJM. 2019;112(6):409-419. doi:10.1093/qjmed/hcz037

Tarashkevich, N. V. The effectiveness of the molecular genetic method GeneXpert MTB/RIF for the diagnosis of tuberculosis / N. V. Tarashkevich, E. S. Kamenko. // New tasks of modern medicine : materials of the III International Scientific Conference (St. Petersburg, December 2014). — St. Petersburg : Zanevskaya Square, 2014. — pp. 68-70.

Sun Q, Sha W, Xiao HP, Tian Q, Zhu H. Evaluation of cerebrospinal fluid adenosine deaminase activity for the differential diagnosis of tuberculous and nontuberculous meningitis. Am J Med Sci. 2012;344(2):116-121. doi:10.1097/MAJ.0b013e318238fee3

Rana SV, Chacko F, Lal V, et al. To compare CSF adenosine deaminase levels and CSF-PCR for tuberculous meningitis. Clin Neurol Neurosurg. 2010;112(5):424-430. doi:10.1016/j.clineuro.2010.02.012

Pereira GR, Barbosa MS, Dias NJD, Dos Santos FF, Rauber KA, Silva DR. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil. Respir Med. 2020;162:105876. doi:10.1016/j.rmed.2020.105876

tuberkulozis marTva . klinikuri praqtikis erpvnuli rekomendacia (gaidlaini)n. qiria z. avaliani ,vivian koqsi ,m. janjRava,r.aspinZelaSvili ,n. lomTaZe ,q. barbaqaZe ,l. kupreiSvili,S.sabanaZe,l.goginaSvili,l.mumlaZe,S. gogiSvili ,s.vaSakiZe ,g.xosiaSvili,k.vaWaraZe,m.maZRaraSvili,m. daviTaSvili, l.papitaSvili 2022 weli

Published

2023-10-10

How to Cite

Avaliani, Z. R., Sabanadze, S. R., Bakuradze, T. D., Trapaidze, L., & Uznadze, N. G. (2023). Clinical spectrum of the central nervous system tuberculosis in the National Center of Tuberculosis and Pulmonary Diseases in Tbilisi, and the difficulties of its diagnosis. The Caucasus Journal of Medical and Psychological Sciences, 1(2-3), 31–50. https://doi.org/10.61699/cjmps-v1-i2-3-p31-50

Issue

Section

Articles